Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01515865 · ClinicalTrials.gov registry record · Phase 4
Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
A Phase 4 study, sponsored by Shire.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
NCT01515865 is a Phase 4 study that has completed, run by Shire. The registered enrollment target is 98 participants.
The verdict
NCT01515865, a Phase 4 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
Study Summary
To study the effect of midodrine against the symptoms of orthostatic hypotension
Interventions
- DRUG Placebo
- DRUG Midodrine HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2012-05-23 |
| Est. Completion | 2013-11-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01515865
The ClinicalTrials.gov registry entry for NCT01515865 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01515865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01515865 about?
NCT01515865 is a clinical study titled "Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension". To study the effect of midodrine against the symptoms of orthostatic hypotension
What is the current status of trial NCT01515865?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2012-05-23. Estimated completion is 2013-11-11.
What interventions are being tested in trial NCT01515865?
The interventions under investigation include: Placebo (DRUG), Midodrine HCl (DRUG).
Who is sponsoring clinical trial NCT01515865?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.